AU2002222263A1 - Mutant mycobacteria for use in therapy - Google Patents

Mutant mycobacteria for use in therapy

Info

Publication number
AU2002222263A1
AU2002222263A1 AU2002222263A AU2226302A AU2002222263A1 AU 2002222263 A1 AU2002222263 A1 AU 2002222263A1 AU 2002222263 A AU2002222263 A AU 2002222263A AU 2226302 A AU2226302 A AU 2226302A AU 2002222263 A1 AU2002222263 A1 AU 2002222263A1
Authority
AU
Australia
Prior art keywords
therapy
mutant mycobacteria
mycobacteria
mutant
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002222263A
Inventor
Eric C Boettger
Jo Colston
Peter Sander
Burkhard Springer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Medical Research Council
Original Assignee
Medical Research Council
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medical Research Council filed Critical Medical Research Council
Publication of AU2002222263A1 publication Critical patent/AU2002222263A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/35—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Mycobacteriaceae (F)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/32—Mycobacterium

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AU2002222263A 2000-12-18 2001-12-18 Mutant mycobacteria for use in therapy Abandoned AU2002222263A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0030857.7 2000-12-18
GBGB0030857.7A GB0030857D0 (en) 2000-12-18 2000-12-18 Therapeutic compositions
PCT/GB2001/005617 WO2002050262A2 (en) 2000-12-18 2001-12-18 Mutant mycobacteria for use in therapy

Publications (1)

Publication Number Publication Date
AU2002222263A1 true AU2002222263A1 (en) 2002-07-01

Family

ID=9905322

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002222263A Abandoned AU2002222263A1 (en) 2000-12-18 2001-12-18 Mutant mycobacteria for use in therapy

Country Status (4)

Country Link
US (1) US7122195B2 (en)
AU (1) AU2002222263A1 (en)
GB (1) GB0030857D0 (en)
WO (1) WO2002050262A2 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1594524B1 (en) * 2003-01-21 2012-08-15 Novartis Vaccines and Diagnostics, Inc. Use of tryptanthrin compounds for immune potentiation
DE102004013988A1 (en) * 2004-03-19 2005-10-13 Henkel Kgaa The factor RecA from Bacillus licheniformis and recA-inactivated safety strains for biotechnological production
EP2111232A4 (en) * 2006-07-06 2010-09-08 Rajesh Shah A novel medicinal formulation for inducing an immune response in patients with chronic and recurring infections
US8647641B2 (en) * 2008-10-20 2014-02-11 University Of Zurich Mycobacterium tuberculosis vaccine
CN105709221B (en) 2011-04-06 2020-11-17 拜欧瓦克西姆有限公司 Pharmaceutical composition for the prevention and/or treatment of HIV diseases in humans
WO2012137072A1 (en) 2011-04-06 2012-10-11 Biovaxim Limited Therapeutic vaccine compositions inducing tolerance to hiv for treating hiv infections in humans
GB201314873D0 (en) * 2013-08-20 2013-10-02 Univ Cape Town Method for diagnosing tuberculosis in a urine sample

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4684475A (en) * 1984-07-23 1987-08-04 First Brands Corporation Organophosphate and silicate containing antifreeze
DE19857398B4 (en) * 1998-12-12 2010-07-08 GM Global Technology Operations, Inc., Detroit Fuel cell system, in particular for electric motor driven vehicles

Also Published As

Publication number Publication date
US7122195B2 (en) 2006-10-17
WO2002050262A3 (en) 2002-09-06
GB0030857D0 (en) 2001-01-31
US20040057966A1 (en) 2004-03-25
WO2002050262A2 (en) 2002-06-27

Similar Documents

Publication Publication Date Title
AUPQ899700A0 (en) Probiotic recolonisation therapy
AU2001235275A1 (en) Adjustable chair
AU2001252135A1 (en) Therapeutic agents
AU2001260327A1 (en) Chair
AU2002230642A1 (en) Proton generating catheters and methods for their use
AU2002258990A1 (en) Improvements in ablation therapy
AU2001291238A1 (en) Portable urinal
AU2001280599A1 (en) Compounds and methods
AU2001253418A1 (en) Compounds and methods
AU9153601A (en) Portable sauna
AU2001245987A1 (en) Compositions and methods for gene therapy
AU2001290078A1 (en) Stem cell therapy
AU2001243394A1 (en) Compounds and methods
AU2002222263A1 (en) Mutant mycobacteria for use in therapy
AUPQ872300A0 (en) Compounds and methods
AU2002225749A1 (en) Powered periotome
AU2001270129A1 (en) Human phosphodiesterases
AU2001273903A1 (en) Therapeutic agents
AU2002234165A1 (en) Combination therapy using pentafluorobenzenesulfonamides and antineoplastic agents
AU2001286341A1 (en) Therapeutic bio-energy unit
AU2001278951A1 (en) Compounds and methods
AU2001252200A1 (en) Chair
AU2002215111A1 (en) Ruthenium-aryl-compounds in cancer therapy
AU2001278776A1 (en) Humidifying unit
AU2001275696A1 (en) Therapeutic agent